Absolute contraindications—(1) platelet count <50 × 109/L and (2) serious bleeding tendencies and coagulation disorders that cannot be improved in the short term (prothrombin time >18 s, prothrombin time activity <40%). Here, F2 is linked to blood coagulation disease.